HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by GOLDSTEIN, D. P. Articles by BERNSTEIN, M. R. Search for Related Content PubMed PubMed Citation Articles by GOLDSTEIN, D. P. Articles by BERNSTEIN, M. R.

Methotrexate With Citrovorum Factor Rescue for Gestational Trophoblastic Neoplasms

From the Division of Gynecologic Oncology, the New England Trophoblastic Disease Center, the Department of Obstetrics and Gynecology at Harvard Medical School, and the Trophoblastic Tumor Service at Boston Hospital for Women, Boston, Massachusetts.

Thirty-five patients with nometastatic gestational trophoblastic neoplasms and 3 patients with metastatic gestational trophoblastic neoplasms were treated primarily with methotrexate and citrovorum factor rescue. The antecedent pregnancy was molar in all patients. The known histologic diagnosis in 34 patients was hydatidiform mole and choriocarcinoma in 3. Up to March 1977, the duration of remissions ranged from 1 to 21 months. Complete and sustained remission was achieved in 91% of patients with nonmetastatic disease and in 2 of the 3 patients with metastases, without evidence of marrow or hepatic and with substantially reduced epithelial toxicity. Response to treatment and the number of courses required to achieve remission were determined solely on the basis of the human chorionic gonadotropin response as measured by the beta subunit radioimmunoassay.